Search
164 studies match these filters. Showing 126–150 of 164 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07546929 | HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed | Recruiting | Phase 2 | 300target | 25 / 1 | 2023 | Apr 23, 2026 | |
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 832 sites in total · contact listed | Recruiting | Phase 3 | 1,670target | 832 / 4 | 2021 | Apr 23, 2026 | |
| NCT03723928 | S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as t… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 723 sites in total | Recruiting | Not applicable | 739target | 723 / 3 | 2018 | Apr 2, 2026 | |
| NCT07606066 | A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions. ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 76 sites in total | Recruiting | 2,150target | 76 / 7 | 2026 | Aug 25, 2026 | ||
| NCT06438315 | SuperSaturated Oxygen Comprehensive Observational Registry The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-effectiveness of SSO2 Therapy versus PCI alone among patients with anterior AMI in routine clinical practice. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total · contact listed | Recruiting | 1,000target | 25 / 1 | 2024 | Aug 20, 2026 | ||
| NCT07282743 | Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatment arms (GL0034, on… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 21 sites in total | Recruiting | Phase 2 | 285target | 21 / 2 | 2026 | Mar 18, 2026 | |
| NCT07046260 | Prospective Study to Assess a Diagnostic Aid for Cancer The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer. ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 39 sites in total · contact listed | Recruiting | 1,650target | 39 / 1 | 2025 | Mar 11, 2026 | ||
| NCT02474160 | Collection and Storage of Tissue and Blood Samples From Patients With Cancer This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs. ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 140 sites in total | Recruiting | 5,000target | 140 / 1 | 2015 | Mar 5, 2026 | ||
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed | Recruiting | 75,000target | 279 / 6 | 2015 | Aug 25, 2026 | ||
| NCT04153292 | The ENCIRCLE Trial This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 68 sites in total | Recruiting | Not applicable | 900target | 68 / 6 | 2020 | Feb 25, 2026 | |
| NCT06906562 | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 2 | 40target | 109 / 1 | 2025 | Feb 17, 2026 | |
| NCT04729114 | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their canc… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total | Recruiting | Phase 1 | 174target | 25 / 2 | 2021 | Feb 4, 2026 | |
| NCT03072927 | MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients t… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 2,388 sites in total · contact listed | Recruiting | 8,000target | 2,388 / 1 | 2017 | Sep 4, 2026 | ||
| NCT06779630 | Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) \>36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total | Recruiting | Not applicable | 150target | 23 / 6 | 2025 | Jul 24, 2026 | |
| NCT07090161 | Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 28 sites in total | Recruiting | Phase 2 | 240target | 28 / 1 | 2025 | Feb 27, 2026 | |
| NCT04820764 | EFS of the CardioMech MVRS Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 12 sites in total · contact listed | Recruiting | Not applicable | 25target | 12 / 1 | 2021 | Feb 10, 2026 | |
| NCT06060041 | IC-8 Apthera IOL New Enrollment Post Approval Study The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 14 sites in total | Recruiting | 435target | 14 / 1 | 2023 | Jan 12, 2026 | ||
| NCT05061004 | Cephea Early Feasibility Study The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed | Recruiting | Not applicable | 90target | 22 / 2 | 2022 | Sep 11, 2026 | |
| NCT06545955 | A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3 months. In this trial, the safety and efficacy of intravesical instillation of nadofaragene firaden… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total | Recruiting | Phase 3 | 250target | 76 / 7 | 2024 | Aug 6, 2026 | |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed | Recruiting | Phase 2 | 88target | 9 / 1 | 2020 | Nov 10, 2025 | |
| NCT05929768 | Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells fr… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 963 sites in total · contact listed | Recruiting | Phase 3 | 2,400target | 963 / 3 | 2023 | Nov 5, 2025 | |
| NCT05304585 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (V… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 181 sites in total · contact listed | Recruiting | Phase 3 | 205target | 181 / 4 | 2022 | Aug 25, 2026 | |
| NCT06990867 | Optimizing Reperfusion to Improve Outcomes and Neurologic Function The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 83 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 740target | 83 / 18 | 2025 | Mar 13, 2026 | |
| NCT04889872 | PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 80 sites in total | Recruiting | Not applicable | 2,250target | 80 / 6 | 2021 | Dec 17, 2025 | |
| NCT06556654 | Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE) The GORE Tissue Reinforcement for Breast Reconstruction (TRBR) research study will look at breast reconstruction during mastectomy procedures. There will be two arms in this study, a Treatment Arm, where data will be collected for a new medical device called the Tissue Reinforcement for Breast Recon… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed | Recruiting | Not applicable | 180target | 20 / 1 | 2025 | Oct 23, 2025 |